Statistics

Total Visits

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer7

Select a period of time:

Number of views in the range

Views
Subgroup analyses from an international, doubleblind, randomised, phase 3 trial evaluating the effect of denosumab on bone metastasis-free survival in men with castrate-resistant prostate cancer5

Views

Views
May 20243
June 20240
July 20241
August 20241
September 20240
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago3